Nucleic acid encoding feline CD86
AssigneesSchering-Plough Animal Health Corporation, The Texas A&M University System
InventorsEllen W. Collisson, InSoo Choi, Barbara J. Winslow, Mark D. Cochran
Life of this patent
Estimating the term…
Abstract
The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid encoding feline CD80, feline CD86, feline CD28, or feline CTLA-4. The present invention provides a host cells transformed with CD80-encoding vectors, CD86-encoding vectors, CD28-encoding vectors, or CTLA-4-encoding vectors. The invention provides polypeptides encoded by the nucleic acid of feline CD80, feline CD86, feline CD28, or feline CTLA-4.
Claims3
An isolated nucleic acid encoding a feline CD86 or a feline soluble CD86 ligand consisting essentially of the nucleotide sequence of SEQ ID NO:
- 5.
An isolated nucleic acid consisting essentially of a nucleotide sequence which encodes a feline CD86 ligand or a feline soluble CD86 ligand of SEQ ID NO:6.
Dependencies are inferred from the claim text.